Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases

Neurotherapeutics - United States
doi 10.1007/s13311-016-0486-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search